Intra-Cellular Therapies Inc. buy melinda
Start price
30.08.17
/
50%
€16.35
Target price
27.12.17
€22.55
Performance (%)
-14.01%
End price
27.12.17
€14.06
Summary
This prediction ended on 27.12.17 with a price of €14.06. The prediction for Intra-Cellular Therapies Inc. disappointed with a performance of -14.01%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% | 61.268% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% | 90.629% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% | 67.985% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% | 62.518% |
Comments by melinda for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Therapien
ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018
(Vom Mitglied beendet)
Stopped prediction by melinda for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€11.81
04.04.19
04.04.19
€18.04
04.11.21
04.11.21
233.36%
05.11.21
05.11.21
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€18.13
30.08.17
30.08.17
€25.00
27.12.17
27.12.17
-14.01%
27.12.17
27.12.17